Leena Peltonen-Palotie

Leena Peltonen-Palotie
Born (1952-06-16)16 June 1952
Helsinki, Finland
Died 11 March 2010(2010-03-11) (aged 57)[1][2]
Helsinki, Finland
Citizenship Finland
Fields Molecular geneticist
Institutions University of OULU,
National Public Health Institute of Finland,
UCLA Department of Human Genetics,
Academy of Finland,
Wellcome Trust Sanger Institute,[3]
Orion Corporation
Alma mater University of Oulu

Leena Peltonen-Palotie (16 June 1952 11 March 2010[4]) was a Finnish geneticist who contributed to the identification of 15 genes for Finnish heritage diseases, including arterial hypertension, schizophrenia, lactose intolerance, arthrosis and multiple sclerosis. She was considered one of the world's leading molecular geneticists.[4][5]

Peltonen-Palotie was born in Helsinki, but moved to Oulu while she was just five years old. She graduated from the Finnish Co-educational Lycée of Oulu in 1971. Peltonen-Palotie received her license (Licentiate of Medicine) in 1976 and in 1978, presented her dissertation to graduate to Doctor of Science in Medicine from the University of Oulu.[6]

Peltonen-Palotie worked at the National Public Health Institute of Finland 1987–1998. From 1998 to 2002 she helped found the UCLA Department of Human Genetics.[7] She had a professorial position in the Academy of Finland since 2003. In April 2005 Peltonen-Palotie was employed in the University of Helsinki and the National Public Health Institute of Finland. She was also the project director in the EU project GenomEUtwin that was formed to define and characterize the genetic components in the background of different diseases. In 2004 she became a member of the Board of Directors of Orion Corporation, the largest Finnish pharmaceutical company. In September 2007, Peltonen-Palotie joined the Wellcome Trust Sanger Institute as the head of Human Genetics. She also headed research groups at the Broad Institute of MIT and Harvard University.[5]

Peltonen-Palotie published over 500 research articles and almost 80 invited articles,[8] and mentored over 70 PhD students in her career.[5] In addition to many academic awards she received honorary degrees from the University of Uppsala and the University of Joensuu. In 2006, Peltonen-Palotie was awarded the Belgian prize Prix van Gysel and the Swedish prize Stora Fernströmpriset. In 2009, she was awarded the honorary title of Academician of Science in Finland.[4]

In 2004 the Finnish television show, Suuret suomalaiset, listed Peltonen-Palotie as 77th of the 100 greatest Finns of all time. On International Women's Day 2010, her achievements were honored in the form of a commemorative postage stamp issued by the Finnish Post.[5]

Peltonen-Palotie was married to fellow molecular geneticist, Aarno Palotie,[9] with whom she had two children.[5] She died on 11 March 2010[4] from bone cancer.[10]

References

  1. van Ommen, Gertjan (2010). "Obituary: Leena Peltonen-Palotie (1952–2010) A visionary in medical genetics.". Nature 464 (7291): 992–992. doi:10.1038/464992a. PMID 20393553.
  2. Pincock, S. (2010). "Leena Peltonen-Palotie". The Lancet 375 (9726): 1604–1608. doi:10.1016/S0140-6736(10)60693-9.
  3. http://www.sanger.ac.uk/research/faculty/lpeltonen/ Professor Leena Peltonen at the Wellcome Trust Sanger Institute
  4. 1 2 3 4 "Obituary: Professor Leena Peltonen-Palotie, Academician of Science". Helsinki: Academy of Finland. 11 March 2010. Retrieved 11 March 2010.
  5. 1 2 3 4 5 "Leena Peltonen-Palotie (1952–2010) – Internationally renowned geneticist dies at 57". Helsingin Sanomat. 11 March 2010. Retrieved 11 March 2010.
  6. Alanikula, Sanna; Laine, Senni (2009-10-30). "Tieteen akateemikolle riittää vielä haasteita". Kaleva (in Finnish) (Oulu). Retrieved 2015-05-20.
  7. "In Memoriam: Leena Peltonen". Retrieved 17 November 2010.
  8. Peltonen, Leena at ISIHighlyCited.com
  9. http://www.sanger.ac.uk/research/faculty/apalotie/ Dr Aarno Palotie
  10. "Leena Palotie kuoli syöpään" (in Finnish). Ilta-Sanomat. 11 March 2010. Retrieved 11 March 2010.
This article is issued from Wikipedia - version of the Monday, February 22, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.